Phytoadaptogen correction of clinical and immunobiological parameters in patients with benign prostatic hyperplasia.
Correction of hormonal, immune, interferon, and antioxidant status and genetic abnormalities with a complex phytoadaptogen leads to positive clinical effects in elderly patients with benign prostatic hyperplasia.